Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/14 → 12/31/14 |
Funding
- TaiRx, Inc.
- Efficient Pharma Management Corp.
Molecular mechanisms underlying TRX-818 suppression of melanoma tumor cell vasculogenic mimicry (VM)
- Seftor, Richard E B (PD/PI)
Project: Research project